Evidence map›Paper›PMID 30261838›Full record

ArticleBMC genomics2018

Correction to: Genomic characterization of three novel Basilisk-like phages infecting Bacillus anthracis.

J Farlow, D Bolkvadze, L Leshkasheli, I Kusradze, A Kotorashvili, N Kotaria, N Balarjishvili, L Kvachadze, M Nikolich, M Kutateladze

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC genomics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 92% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

J FarlowFarlow Scientific Consulting Company, LLC, Lewiston, UT, USA. farlowscience@gmail.com.
D BolkvadzeGeorge Eliava Institute for Bacteriophages, Microbiology and Virology, Tbilisi, Georgia.
L LeshkasheliGeorge Eliava Institute for Bacteriophages, Microbiology and Virology, Tbilisi, Georgia.
I KusradzeGeorge Eliava Institute for Bacteriophages, Microbiology and Virology, Tbilisi, Georgia.
A KotorashviliLugar Center for Public Health Research at National Center for Disease Contro, Tbilisi, Georgia.
N KotariaLugar Center for Public Health Research at National Center for Disease Contro, Tbilisi, Georgia.
N BalarjishviliGeorge Eliava Institute for Bacteriophages, Microbiology and Virology, Tbilisi, Georgia.
L KvachadzeGeorge Eliava Institute for Bacteriophages, Microbiology and Virology, Tbilisi, Georgia.
M NikolichDepartment of Bacteriophage Therapeutics, Bacterial Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, Silver Spring, MD, USA.
M KutateladzeGeorge Eliava Institute for Bacteriophages, Microbiology and Virology, Tbilisi, Georgia.
George Eliava Institute of Bacteriophage, Microbiology and Virology · GENational Center for Disease Control and Public Health · GEScientific Consulting Group · USWalter Reed Army Institute of Research · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Following the publication of this article [1], the authors noted two typographical errors: one in Table 1 with regard to the location of the Basilisk Phage, which was incorrectly captured as "Kutaisis, country of Georgia Utah, USA" but should be "Utah, USA".

Identifiers

PMID30261838
PMCPMC6158857
OpenAlexW2893645589

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.